Jeonjinbio Co., Ltd. announced that it expects to receive KRW 6.3 billion in funding from Korea Investment & Securities Co., Ltd., Shinhan Financial Investment Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, and other investors
July 06, 2021
Share
Jeonjinbio Co., Ltd. announced a private placement of 8th series non-guaranteed private equity convertible bond for gross proceeds of KRW 6,300,000,000 on July 7, 2021. The transaction will include participation from Suseong KOSDAQ Venture B2 Specialized Investment Criminal Placement Trust, a fund managed by Korea Investment & Securities Co., Ltd. for KRW 500,000,000, Suseong KOSDAQ Venture B3 Specialized Investment Criminal Placement Trust, a fund managed by KB Securities Co., Ltd., Investment Arm for KRW 1,000,000,000, Suseong KOSDAQ Venture B4 Specialized Investment Criminal Investment Trust, a fund managed by Shinhan Financial Investment Co., Ltd., Investment Arm for KRW 1,000,000,000, Lee, Jin-Soo for KRW 700,000,000, Kim, Woo-jung for KRW 300,000,000, Oh, Ki-cheol for KRW 900,000,000, Ryu Gun-woo for KRW 500,000,000, lecture room for KRW 300,000,000, Oh Hyun-ah for KRW 300,000,000, Kim Geun-bae for KRW 200,000,000, Seo Joo-eun for KRW 200,000,000 and Kang Seong-gil for KRW 200,000,000. The bonds have a coupon rate of 1% and maturity date of July 09, 2024. The bonds are convertible into 705,408 common shares representing 10.01% stake at a conversion price of KRW 8,931 and the conversion period of the bonds will start from July 09, 2022 and end on June 09, 2024. The transaction has been approved by the board of directors of the company. The payment date and subscription date of the transaction is July 9, 2021. The bonds are subject to prohibition of exercise for 1 year.
JEONJIN BIO CO.,LTD is a company mainly engaged in the production and sale of harmful animal damage reduction products. The harmful animal damage reduction products include bird, mammal, reptile, pest and parasitic damage reduction agents. In addition, the Company manufactures and sells insecticide fragrance. The Company distributes its products within the domestic market and to overseas markets.
Jeonjinbio Co., Ltd. announced that it expects to receive KRW 6.3 billion in funding from Korea Investment & Securities Co., Ltd., Shinhan Financial Investment Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, and other investors